Last reviewed · How we verify
GONAL-f®
GONAL-f® is a Small molecule drug developed by Merck KGaA, Darmstadt, Germany. It is currently FDA-approved. Also known as: r-hFSH, Follitropin alfa, Recombinant follicle stimulating hormone (r-FSH), Recombinant human follicle stimulating hormone.
At a glance
| Generic name | GONAL-f® |
|---|---|
| Also known as | r-hFSH, Follitropin alfa, Recombinant follicle stimulating hormone (r-FSH), Recombinant human follicle stimulating hormone, follitropin alfa |
| Sponsor | Merck KGaA, Darmstadt, Germany |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin (PHASE1)
- Comparison of Follitropin Delta and Follitropin Alfa in Combination With Menotropin
- Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation. (PHASE3)
- Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers (PHASE1)
- PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study (PHASE4)
- Ovarian Hyperstimulation and Fibrin Clot Properties. (NA)
- NATural Ovarian Stimulation (PHASE4)
- Is the Diurnal Variation in Circulating Levels of Cortisol Reflected in Follicular Fluid of Preovulatory Follicles Close to Ovulation?
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GONAL-f® CI brief — competitive landscape report
- GONAL-f® updates RSS · CI watch RSS
- Merck KGaA, Darmstadt, Germany portfolio CI
Frequently asked questions about GONAL-f®
What is GONAL-f®?
GONAL-f® is a Small molecule drug developed by Merck KGaA, Darmstadt, Germany.
Who makes GONAL-f®?
GONAL-f® is developed and marketed by Merck KGaA, Darmstadt, Germany (see full Merck KGaA, Darmstadt, Germany pipeline at /company/merck-kgaa-darmstadt-germany).
Is GONAL-f® also known as anything else?
GONAL-f® is also known as r-hFSH, Follitropin alfa, Recombinant follicle stimulating hormone (r-FSH), Recombinant human follicle stimulating hormone, follitropin alfa.
What development phase is GONAL-f® in?
GONAL-f® is FDA-approved (marketed).
Related
- Manufacturer: Merck KGaA, Darmstadt, Germany — full pipeline
- Also known as: r-hFSH, Follitropin alfa, Recombinant follicle stimulating hormone (r-FSH), Recombinant human follicle stimulating hormone, follitropin alfa
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing